TGFB1 and malignant colon neoplasm: We also analyzed the adjuvant activity of pApo, pSpP144 and pApoLinkerP144 in prophylactic vaccination of BALB/c mice with the AH-1 peptide derived from CT26 colon cancer, a setting where TGF-β blockade has been shown to enhance antitumor immune responses [19].